Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Ruoqian Cheng"'
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Recombinant human growth hormone (rhGH) therapy is beneficial for children with Prader–Willi syndrome (PWS) in improving short stature and metabolism, but the effect of early rhGH treatment on respiratory and sleep parameters fo
Externí odkaz:
https://doaj.org/article/ef4ee798618b47149170cde64ad4b678
Autor:
Zhuo Chang, Wei Lu, Zhuhui Zhao, Li Xi, Xiaojing Li, Rong Ye, Jinwen Ni, Zhou Pei, Miaoying Zhang, Ruoqian Cheng, Zhangqian Zheng, Chengjun Sun, Jing Wu, Feihong Luo
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-14 (2021)
Abstract Background Primary adrenal insufficiency (PAI) is life-threatening, and a definitive aetiological diagnosis is essential for management and prognostication. We conducted this study to investigate the genetic aetiologies of PAI in South China
Externí odkaz:
https://doaj.org/article/4a16a44451494286a10efbdc7806f2c2
Autor:
Jingyu You, Xianying Cheng, Xiaojing Li, Mingqing Li, Li Yao, Feihong Luo, Ruoqian Cheng, Li Xi, Jiangfeng Ye
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background The gold standard for the diagnosis of central precocious puberty (CPP) is gonadotropin-releasing hormone (GnRH) or GnRH analogs (GnRHa) stimulation test. But the stimulation test is time-consuming and costly. Our objective was to
Externí odkaz:
https://doaj.org/article/2040cba16169408ea1a508650b14140d
Autor:
Chengjun Sun, Biao Lu, Yu Liu, Yaqin Zhang, Haiyan Wei, Xu Hu, Pei Hu, Qian Zhao, Yanling Liu, Kan Ye, Kan Wang, Zaiyan Gu, Zheng Liu, Jin Ye, Hongxiao Zhang, Hong Zhu, Zhihong Jiang, Yanjie Liu, Naijun Wan, Chengming Yan, Jianying Yin, Lirong Ying, Feng Huang, Qingjin Yin, Li Xi, Feihong Luo, Ruoqian Cheng
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/bbe5b7dfc9c748a486e03125b95e8b27
Autor:
Chengjun Sun, Biao Lu, Yu Liu, Yaqin Zhang, Haiyan Wei, Xu Hu, Pei Hu, Qian Zhao, Yanling Liu, Kan Ye, Kan Wang, Zaiyan Gu, Zheng Liu, Jin Ye, Hongxiao Zhang, Hong Zhu, Zhihong Jiang, Yanjie Liu, Naijun Wan, Chengming Yan, Jianying Yin, Lirong Ying, Feng Huang, Qingjin Yin, Li Xi, Feihong Luo, Ruoqian Cheng
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
ContextLong-acting recombinant human growth hormone (rhGH) has transformed growth hormone deficiency (GHD) treatment. However, the possibility and rationality for flexible time regimen are pending.ObjectiveWe studied the efficacy of biweekly versus w
Externí odkaz:
https://doaj.org/article/342716233f3f4e22bd958dab3aed79f3
Autor:
Dandan Xu, Chengjun Sun, Zeyi Zhou, Bingbing Wu, Lin Yang, Zhuo Chang, Miaoying Zhang, Li Xi, Ruoqian Cheng, Jinwen Ni, Feihong Luo
Publikováno v:
BMC Medical Genetics, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background Mutations in the aggrecan (ACAN) gene can cause short stature (with heterogeneous clinical phenotypes), impaired bone maturation, and large variations in response to growth hormone (GH) treatment. For such cases, long-term longitu
Externí odkaz:
https://doaj.org/article/7be66b129ed44e0aab607e7ff0290371
Autor:
Meng Yuan, Yuanyuan Shan, Fanshu Xu, Lin Yang, Chengjun Sun, Ruoqian Cheng, Bingbing Wu, Zhehuan Zhang, Yun Cao, Rong Zhang, Wenhao Zhou, Guoqiang Cheng, Liyuan Hu
Publikováno v:
Translational Pediatrics. 12:86-96
Autor:
Lin Yang, Bo Liu, Xinran Dong, Jing Wu, Chengjun Sun, Li Xi, Ruoqian Cheng, Bingbing Wu, Huijun Wang, Shiyuan Tong, Dahui Wang, Feihong Luo
Publikováno v:
Osteoporosis International. 33:1373-1384
Osteogenesis imperfecta (OI) is a genetic disease with an estimated prevalence of 1 in 13,500 and 1 in 9700. The classification into subtypes of OI is important for prognosis and management. In this study, we established a clinical severity predictio
Autor:
Miaoying Zhang, Zhangqian Zheng, Li Xi, Rong Ye, Jinwen Ni, Jing Wu, Zhuo Chang, Zhuhui Zhao, Xiaojing Li, Zhou Pei, Wei Lu, Chengjun Sun, Feihong Luo, Ruoqian Cheng
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-14 (2021)
BMC Medical Genomics
BMC Medical Genomics
Background Primary adrenal insufficiency (PAI) is life-threatening, and a definitive aetiological diagnosis is essential for management and prognostication. We conducted this study to investigate the genetic aetiologies of PAI in South China and expl
Autor:
Xiaoping Luo, Sha Zhao, Yu Yang, Guanping Dong, Linqi Chen, Pin Li, Feihong Luo, Chunxiu Gong, Zhuangjian Xu, Xu Xu, Haihong Gong, Hongwei Du, Ling Hou, Yan Zhong, Qiao Shi, Xuefeng Chen, Xiuli Chen, Liya Xu, Ruoqian Cheng, Chang Su, Yaping Ma, Lulian Xu, Lina Zhang, Honghua Lu
Publikováno v:
European journal of endocrinology. 187(5)
Objective To evaluate the safety and efficacy of weekly PEGylated-recombinant human growth hormone (PEG-rhGH) in children with idiopathic short stature (ISS) in China. Design and methods This was a multicenter, phase II study in which all subjects we